Targeted kinase profiling Strong emphasis on real-time, quantitative kinase and phosphatase assays with a large catalog of optimized substrates suggests a sales opportunity to provide broader target panels, custom assay development, and integration into existing screening workflows for drug discovery programs.

Real-time efficiency PhosphoSens technology enables faster data generation and richer mechanistic insights, presenting a compelling value proposition for teams seeking to accelerate hit-to-lead processes, improve rank-ordering of candidates, and reduce time to candidate selection.

Flexible throughput Capability across high, moderate, and low throughput modes indicates readiness to support both early-stage discovery and later-stage profiling, which aligns with potential customers across academia, biotech startups, and mid-size pharma looking for scalable assay solutions.

Service and transfer Offerings include assay transfer, screening, potency, and profiling services, providing a pathway for customers to de-risk early investments or outsource specialized assays, potentially expanding into joint development or sponsored projects.

Expanded partnerships With a revenue range in the tens of millions and active funding, there is room to pursue strategic collaborations, co-development of novel substrates, and licensing of PhosphoSens technology to larger CROs or pharma companies seeking differentiated assay platforms.